|
| Monday, 10 February 2020, 15:00 HKT/SGT | |
| |  | |
Source: Meiogenix | |
|
|
|
Monheim, Germany and Paris, France, Feb 10, 2020 - (ACN Newswire) - Bayer and Meiogenix, a biotech company focused on next-generation breeding technologies, announced today a collaboration to advance agricultural research and development by accelerating the development of Meiogenix's proprietary technologies related to plant breeding and genome editing applications. This new research collaboration has the potential to deliver much-needed plant health and nutrition improvements to food crops so farmers can more efficiently and sustainably grow improved plant varieties that deliver the types of foods consumers want.
 | | Figure 1: Plants Genetic Diversity - To view an enhanced version of Figure 1, please visit: https://orders.newsfilecorp.com/files/6942/52265_3248f08fd41dbbdb_001full.jpg |
"Farmers need innovative solutions as they face limited natural resources and a changing climate," said Jeremy Williams, Head of Plant Biotechnology, Crop Science Research & Development (R&D) at Bayer. "Access to Meiogenix's proprietary technologies could improve the precision and speed with which our breeders enhance crops, which could ultimately accelerate those solutions for the diverse needs of people and our planet."
Meiogenix's proprietary technologies are used to induce the exchange of genomic regions between chromosomes of plant cells during meiosis, the natural process that generates genetic diversity during plant breeding. Technologies based on meiotic recombination provide commercial crops with access to a broader genetic diversity, including complex traits for improved food quality, plants' resistance to diseases and pests, and higher yield potential. The resulting hybrids and varieties have the potential to deliver value throughout the food chain, from farmers to consumers.
"Over the past decade, we have assembled unique know-how, intellectual property portfolio and network of experts to help generate biodiversity and accelerate breeding through modulating meiotic recombination. We are proud to collaborate with Bayer to develop the next generations of crops," said Giacomo Bastianelli, Co-founder & CEO of Meiogenix.
"Agriculture is facing the challenge of adjusting plant physiology to rapid climate, pest and disease changes, as well as preparing the next generation of healthier food. Collaborating on these new breeding technologies will be key to bringing innovative solutions to farmers and consumers," said Luc Mathis, strategic advisor of Meiogenix.
As part of the project, Meiogenix will collaborate with top academic institutes to advance these technologies in crops.
Bayer offers a wide range of educational materials regarding plant breeding and gene editing technologies on its website.
Find more information at www.bayer.com and at www.meiogenix.com
Press Contact
Bayer: Holger Elfes, +49 2173 38-3270, holger.elfes@bayer.com
Meiogenix: Caroline Carmagnol, +33 6 64 18 99 59, caroline@alizerp.com
Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties, and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
Related Links
Meiogenix Technologies https://www.newsfilecorp.com/redirect/bL0xiyao
Breeding and gene editing at Bayer https://www.newsfilecorp.com/redirect/3ALgsvEX
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/52265
Topic: Press release summary
Source: Meiogenix
Sectors: Agritech, BioTech
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
| |
Latest Press Releases
Elastos' BeL2 Secures Starknet Grant to Advance Native Bitcoin Lending and DeFi Solutions
July 31, 2024 18:00 HKT/SGT
|
|
|
Honda 0 Series Concept Model, Saloon, Wins "Red Dot: Best of the Best 2024" Award in Red Dot Award: Design Concept 
Wednesday, July 31, 2024 3:33:00 PM
|
|
|
New Clinical Data Demonstrates Three Years of Continuous Treatment with Dual-Acting LEQEMBI (lecanemab-irmb) Continues to Significantly Benefit Early Alzheimer's Disease Patients Presented at AAIC 2024
Wednesday, July 31, 2024 12:59:00 PM
|
|
|
New Gonow RV Announces Platinum Sponsorship of Prestigious "Ball on the Wall" Event
July 31, 2024 12:40 HKT/SGT
|
|
|
MHI and QST Complete Outer Vertical Target Prototype of the Divertor for the ITER in Southern France
Wednesday, July 31, 2024 11:50:00 AM
|
|
|
Fabwelt & Blockpass Jointly Build Trust, Fight Fraud in Blockchain Gaming
July 31, 2024 11:00 HKT/SGT
|
|
|
In Historic First: Rockbird Media Brings Retail & E-Commerce Summit Asia to Vietnam
July 31, 2024 09:53 HKT/SGT
|
|
|
Kaplan Fox & Kilsheimer LLP is Investigating Grifols SA (GRFS) for Potential Securities Law Violations
July 31, 2024 09:44 HKT/SGT
|
|
|
Photonis Showcases Advanced Nuclear Instrumentation Solutions at Utility Working Conference
July 30, 2024 23:00 HKT/SGT
|
|
|
Dual-action therapy shows promise against aggressive oral cancer
July 30, 2024 20:00 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
